Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial

BACKGROUND: Agitation in Alzheimer’s disease (AD) is common and associated with poor patient life-quality and carer distress. The best evidence-based pharmacological treatments are antipsychotics which have limited benefits with increased morbidity and mortality. There are no memantine trials in cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Fox, Chris, Crugel, Monica, Maidment, Ian, Auestad, Bjorn Henrik, Coulton, Simon, Treloar, Adrian, Ballard, Clive, Boustani, Malaz, Katona, Cornelius, Livingston, Gill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342281/
https://www.ncbi.nlm.nih.gov/pubmed/22567095
http://dx.doi.org/10.1371/journal.pone.0035185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342281/
https://www.ncbi.nlm.nih.gov/pubmed/22567095
http://dx.doi.org/10.1371/journal.pone.0035185

Ejemplares similares